Table 3.
Difference in 5-year survival rate in 132 patients with neuroendocrine tumors by age, gender, tumor size, lymph node metastasis, distant metastasis, radical excision, pathological grade, and synaptophysin and chromogranin A expression
| n | 5-yr survival rate | χ2 | P value | ||
| Age (yr) | < 55 | 73 | 83.6 | 0.554 | 0.457 |
| ≥ 55 | 59 | 88.1 | |||
| Gender | Male | 83 | 80.7 | 4.327 | 0.038 |
| Female | 49 | 93.9 | |||
| Tumor size | < 2 cm | 105 | 98.1 | 64.98 | 0.000 |
| ≥ 2cm | 27 | 37 | |||
| Lymph node metastasis | No | 111 | 91.9 | 22.37 | 0.000 |
| Yes | 21 | 52.4 | |||
| Distant metastasis | No | 127 | 86.6 | 2.765 | 0.096 |
| Yes | 5 | 60 | |||
| Radical excision | No | 16 | 43.8 | 25.89 | 0.000 |
| Yes | 116 | 91.4 | |||
| Pathological grade | G1 + G2 | 104 | 99 | 71.79 | 0.000 |
| NEC | 28 | 35.7 | |||
| Syn | Negative | 14 | 78.6 | 0.629 | 0.428 |
| Positive | 118 | 86.4 | |||
| CgA | Negative | 80 | 83.8 | 0.568 | 0.451 |
| Positive | 52 | 88.5 |
Syn: Synaptophysin; CgA: Chromogranin A; NEC: Neuroendocrine carcinoma.